Literature DB >> 11401890

Diaphragm injury in individuals with airflow obstruction.

N A Macgowan1, K G Evans, J D Road, W D Reid.   

Abstract

The purpose of this study was to describe the nature of diaphragm injury, to quantify the injury and number of macrophages at the light microscopic level, and to determine their association with airflow obstruction in humans. Partial-thickness diaphragm biopsies were obtained from 21 subjects going for thoracotomy surgery (FEV(1): 74 +/- 34% predicted; range: 16 to 122% predicted). Cross sections cut from frozen diaphragm were processed with H&amp;E or processed for immunohistochemistry using the monoclonal antibody Ber-MAC3 (DAKO Corp., Carpinteria, CA) to label macrophages. Area fractions (A(A)) or the proportions of the cross- sectional area were determined by point counting all viable fields of H&amp;E-stained diaphragm cross sections. A(A) were 66.2 +/- 9.0% for normal muscle, 17.6 +/- 7.2% for abnormal muscle, and 16.3 +/- 4.2% for connective tissue. Percent predicted FEV(1) was inversely related to the A(A) of abnormal muscle (r = -0.53, p < 0.01) and directly related to the A(A) of normal muscle (r = 0.37, p < 0.05). The number of macrophages was not related to % predicted FEV(1) (mean +/- SD: 0.41 +/- 0.18/fiber; 52 +/- 19/mm(2)). We conclude that increasing severity of airflow obstruction is associated with an increased A(A) of abnormal diaphragm and a decreased A(A) of normal diaphragm.

Entities:  

Mesh:

Year:  2001        PMID: 11401890     DOI: 10.1164/ajrccm.163.7.2001042

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  Delayed onset muscle soreness after inspiratory threshold loading in healthy adults.

Authors:  Sunita Mathur; A William Sheel; Jeremy D Road; W Darlene Reid
Journal:  Cardiopulm Phys Ther J       Date:  2010-03

2.  Sex differences in function and structure of the quadriceps muscle in chronic obstructive pulmonary disease patients.

Authors:  Pilar Ausín; Juana Martínez-Llorens; Marina Sabaté-Bresco; Carme Casadevall; Esther Barreiro; Joaquim Gea
Journal:  Chron Respir Dis       Date:  2016-12-06       Impact factor: 2.444

3.  Serum skeletal troponin I following inspiratory threshold loading in healthy young and middle-aged men.

Authors:  Glen E Foster; Jiro Nakano; A William Sheel; Jeremy A Simpson; Jeremy D Road; W Darlene Reid
Journal:  Eur J Appl Physiol       Date:  2012-02-10       Impact factor: 3.078

Review 4.  Diaphragm Dysfunction and Rehabilitation Strategy in Patients With Chronic Obstructive Pulmonary Disease.

Authors:  Yuanyuan Cao; Peijun Li; Yingqi Wang; Xiaodan Liu; Weibing Wu
Journal:  Front Physiol       Date:  2022-05-02       Impact factor: 4.755

5.  Respiratory muscle injury, fatigue and serum skeletal troponin I in rat.

Authors:  Jeremy A Simpson; Jennifer Van Eyk; Steve Iscoe
Journal:  J Physiol       Date:  2003-12-12       Impact factor: 5.182

6.  Physiological properties of human diaphragm muscle fibres and the effect of chronic obstructive pulmonary disease.

Authors:  Alison K Stubbings; Alastair J Moore; Michael Dusmet; Peter Goldstraw; Timothy G West; Michael I Polkey; Michael A Ferenczi
Journal:  J Physiol       Date:  2008-03-27       Impact factor: 5.182

7.  Inspiratory muscle training in difficult to wean patients: work it harder, make it better, do it faster, makes us stronger.

Authors:  Stefano Nava; Luca Fasano
Journal:  Crit Care       Date:  2011-04-18       Impact factor: 9.097

8.  Diaphragm adaptations in patients with COPD.

Authors:  Coen A C Ottenheijm; Leo M A Heunks; Richard P N Dekhuijzen
Journal:  Respir Res       Date:  2008-01-24

9.  Prolonged Immobilization Exacerbates the Loss of Muscle Mass and Function Induced by Cancer-Associated Cachexia through Enhanced Proteolysis in Mice.

Authors:  Laura Mañas-García; Antonio Penedo-Vázquez; Adrián López-Postigo; Jorieke Deschrevel; Xavier Durán; Esther Barreiro
Journal:  Int J Mol Sci       Date:  2020-10-31       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.